Enernetics Inc - 02142 Cambridge, MA

Business Name: Enernetics Inc
Categorized In: Research and Development Laboratories
Address: 350 Third St Unit 1111, Cambridge, MA 02142
Phone Number: No number given
Contact Person: Tim Sullivan
NAICS Code: 541712
SIC Code: 8731
Business Type: B2B (Business to Business)
Founding Year: 2010
Employee #: 1 to 4
Location Type: Single Location
Annual Revenue ($): $100.000 to $499.999
Share This Business:
Similar Businesses: Euclides Technologies Inc - Cambridge, MA 02142
Janus Biotherapeutics Inc - Cambridge, MA 02142
Massachusetts Institute Of Technology - Cambridge, MA 02142
Panasonic Technologies Inc - Cambridge, MA 02142
Iptyx Corporation - Cambridge, MA 02142
Thermogen Hague Incorporated - Cambridge, MA 02142
Bgi Americas Corp - Cambridge, MA 02142
Celexion LLC - Cambridge, MA 02142
Theracrine Inc - Cambridge, MA 02142
Alinea Pharmaceuticals - Cambridge, MA 02142
Avicena Group Inc - Cambridge, MA 02142
Aerospace Missions Corporation - Cambridge, MA 02142
Battelle Memorial Institute - Cambridge, MA 02142
Smartworlds LLC - Cambridge, MA 02142
Biogen Idec Hemophilia - Cambridge, MA 02142
Research Institute-Medicine - Cambridge, MA 02142
Verenium Corporation - Cambridge, MA 02142
Kinalco Inc - Cambridge, MA 02142
In Vivo Therapeutics Corp - Cambridge, MA 02142

Enernetics Inc provides professional Research and Development Laboratories from its single location at the coordinates 42.363833,-71.083251.

The company offers B2B variables under the SIC code 8731 and NAICS code 541712, while making an annual revenue of $100.000 to $499.999 and hiring a total of 1 to 4 employees.

Founded in 2010, the company can now be visited at 350 Third St Unit 1111, Cambridge, Massachusetts 02142 or contacted through representative Tim Sullivan at No number given.

For frequently asked questions and further inquiries about professional Research and Development Laboratories, get to know more about Enernetics Inc through its company website at . Engage with this business on its social media platforms through on Twitter and on Facebook.